시장보고서

상품코드

1455684

이식형 제세동기(ICD) 시장 : 제품 유형별, 장치 유형별, NYHA 클래스 유형별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Implantable Cardioverter Defibrillators Market, By Product Type, By Device type, By NYHA Class Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 03월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 284 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

이식형 제세동기(ICD) 시장 규모는 2023년 39억 4,556만 달러로 평가되었고, 2024년부터 2032년까지 연평균 7.41% 성장할 것으로 예상됩니다.

ICD 시장 - 시장 역학

기술 발전과 제품 혁신은 시장 수요를 촉진합니다.

Medtronic의 Epsila EV MRI SureScan 및 Aurora Extravascular(EV)-ICD MRI SureScan과 같은 기술 발전과 제품 발명은 합병증 감소 및 설치 기술 개선과 같은 유망한 솔루션을 제공합니다. 현재 진행 중인 기술 발전, 특히 최근 몇 년동안 목격된 ICD의 놀라운 성공률은 시장의 추가 성장을 가속할 것으로 예상됩니다. 예를 들어, 2022년 8월, 메드트로닉 PLC는 갑작스런 심장마비를 예방하기 위한 혁신적인 저침습적 제세동기 임플란트인 메드트로닉 EV ICD 시스템의 효능을 입증하는 임상연구를 발표했습니다. 이 혈관외 ICD 시스템은 주요 구성요소를 왼쪽 겨드랑이 아래에 배치하고 홀드업 페이싱 요법을 통해 진동을 억제하고 빈맥을 예방하며 제세동 쇼크를 피할 수 있도록 환자를 돕습니다. 이러한 발전은 환자의 예후를 개선하고 위험을 줄이며 심장 치료 기술 발전에 대한 업계의 노력을 강조함으로써 시장에 큰 기여를 하고 있습니다. 또한, 의료 시설에서 ICD의 채택이 증가하고 있는 것도 시장 확대의 주요 요인으로 작용할 것으로 예측됩니다. 예를 들어, 2021년 12월 클리블랜드 클리닉(Cleveland Clinic)은 국제 임상시험의 일환으로 세계 최초로 두 명의 환자에게 무심장 제세동기 시스템을 성공적으로 이식하는 데 성공했습니다. 그 결과, 이 지역에서 ICD의 보급과 심장 리듬 장애의 유병률 증가는 시장 성장을 가속할 것으로 예상됩니다.

ICD 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032) 동안 매년 약 7.41%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

제품 유형별로는 경정맥 ICD가 2023년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

기기 유형별로는 2023년 양심실 기기가 주요 유형으로 부상할 것으로 예상됩니다.

NYHA 클래스별로는 2023년 NYHA 클래스 II가 주요 유형으로 부상할 것입니다.

지역별로는 북미가 2023년 매출 1위

이식형 제세동기 시장 - 세분화 분석 :

ICD 세계 시장은 제품 유형, 장치 유형, NYHA 클래스 유형, 최종 사용자 및 지역을 기준으로 세분화됩니다.

시장은 제품 유형에 따라 경정맥 ICD(T-ICD)와 피하 ICD 부문(S-ICD)로 분류되며, 2023년에는 T-ICD 부문이 시장에서 지배적인 위치를 차지할 것으로 예상됩니다. 이러한 우위는 T-ICD가 생명을 위협하는 심실 부정맥을 관리하고 침습적 수술과 관련된 합병증 및 의료 비용을 줄이는 데 있어 귀중한 이점을 제공하기 때문이며, T-ICD는 영구 박동, 심장 재동기화 치료(CRT), 항빈맥 박동과 같은 기능을 통해 심실세동(VF) 및 심실세동(VF) 및 심실빈맥(VT) 환자의 요구에 대응하고 있습니다.

이 시장은 장치 유형에 따라 단일 챔버 ICD, 이중 챔버 ICD, 양심실 장치 등 세 가지로 분류되며, 2023년에는 양심실 장치 부문이 시장 리더로 부상했습니다. 심장 돌연사 증가, 심박조율기와 제세동기로서의 이중 기능 등의 요인이 CRT-D 장치에 대한 수요를 촉진할 것으로 예상됩니다. 유해한 상태를 신속하게 보고하는 기능과 향상된 페이싱 성능이 결합되어 사망률 감소에 기여하고 있습니다. 또한, 주요 기업들은 이러한 장치를 강화하는 데 주력하고 있습니다. 예를 들어, 2019년 3월 바이오트로닉(BIOTRONIK)은 유럽 시장에서 세계에서 가장 작은 CRT-D 및 ICD 장치를 출시했으며, 3테슬라 전신 MRI 스캔 승인을 받았습니다. 또한 MRI 호환성, 블루투스 기능, 4극 리드 등 이 부문의 기술 발전은 채택률을 높일 수 있는 잠재력을 가지고 있습니다. 예를 들어, 2020년 7월 Abbott는 차세대 블루투스 지원 CRT-D 및 ICD에 대한 FDA 승인을 발표했습니다.

ICD 시장 - 지리적 통찰력

지역적으로는 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 이 지역들은 비즈니스를 가져오는 국가에 따라 더 세분화됩니다.

ICD 시장 - 경쟁 구도 :

ICD 시장에 진출한 기업들은 제품을 강화하기 위해 다양한 전략을 채택하고 있습니다. 이러한 전략에는 최소 침습적 시술을 가능하게 하는 소형화, 배터리 수명 연장 등 기기의 효과와 환자 예후를 개선하기 위한 기술 발전이 포함됩니다. 또한, 각 업체들은 능동적인 환자 관리와 데이터 기반 의사결정을 촉진하기 위해 원격 모니터링 기능을 갖춘 지능형 기기 개발에 주력하고 있습니다. 의료 제공업체 및 연구 기관과의 협업은 지속적인 기술 혁신을 촉진하고 최신 의료 발전을 통합하는 데 있어 매우 중요한 역할을 합니다. 또한, 규제 준수와 엄격한 품질 기준 준수를 위한 노력은 소비자의 신뢰를 강화하고 시장 침투를 촉진하여이식형 제세동기(ICD) 시장의 지속적인 성장을 가속하고 있습니다.

서론
북미
- 개요
- 북미 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 - ICD 업계

경쟁 대시보드
기업 개요
- Abbott
- Medtronic
- BIOTRONIK SE &Co. KG
- Boston Scientific Corporation
- MicroPort Scientific Corporation.
- LivaNova PLC.
- Others

제13장 애널리스트의 전방위 전망

LSH 24.05.02

REPORT HIGHLIGHT

Implantable cardioverter defibrillators Market size was valued at USD 3,945.56 Million in 2023, expanding at a CAGR of 7.41% from 2024 to 2032.

The implantable cardioverter defibrillator (ICD) is an electronic medical device utilized for monitoring and controlling heart rhythms in individuals vulnerable to life-threatening arrhythmias like ventricular tachycardia as well as ventricular fibrillation. Market growth drivers encompass technological advancements, increasing occurrences of sudden cardiac arrest, rising public awareness, and supportive governmental and healthcare organizational policies. Emerging players' innovation efforts, exemplified by MicroPort Scientific Corporation's receipt of a CE mark for its INVICTA line of defibrillation leads in July 2022, also contribute to market expansion. With the escalating prevalence of cardiovascular diseases (CVDs), the demand for advanced cardiac care solutions, including ICDs, is anticipated to surge, presenting opportunities for healthcare sector expansion and advancements.

Implantable cardioverter defibrillators Market- Market Dynamics

Technological progress and product innovations to propel market demand

Technological progress and product inventions, including Medtronic's Epsila EV MRI SureScan along with Aurora Extravascular (EV)-ICD MRI SureScan, offer promising solutions with reduced complications and improved placement techniques. The ongoing technological advancements, particularly the commendable success rates witnessed in recent years for ICDs, are expected to propel further market growth. For instance, in August 2022, Medtronic PLC presented clinical research demonstrating the efficacy of an innovative minimally invasive defibrillator implant, the Medtronic EV ICD system, aimed at preventing sudden cardiac arrest. This extravascular implantable defibrillator scheme, with its main component located beneath the left armpit, delivers holdup pacing therapy to reduce vibrations, prevent tachycardia, and assist patients in avoiding defibrillation shock. Such advancements significantly contribute to the market by enhancing patient outcomes, mitigating risks, and highlighting the industry's commitment to advancing cardiac care technologies. Moreover, the increasing adoption of ICDs within healthcare facilities is poised to be a significant market expansion driver. For instance, in December 2021, Cleveland Clinic successfully conducted leadless pacemaker defibrillator system implants in the first two patients globally as part of an international clinical trial. This innovative device, designed to address both low and elevated heart rates, integrates leadless pacemaker End User with subcutaneous ICDs. Consequently, the growing acceptance of implantable defibrillators and the rising prevalence of cardiac rhythm disorders in the region are expected to drive market growth.

Implantable cardioverter defibrillators Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.41% over the forecast period (2024-2032)

Based on product type segmentation, transvenous implantable cardioverter-defibrillators was predicted to show maximum market share in the year 2023

Based on Device type segmentation, biventricular devices was the leading type in 2023

Based on NYHA Class Type segmentation, NYHA Class II was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Implantable cardioverter defibrillators Market- Segmentation Analysis:

The Global Implantable cardioverter defibrillators Market is segmented on the basis of Product Type, Device type, NYHA Class Type, End User, and Region.

The market is divided into two categories based on product type: transvenous implantable cardioverter-defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillator segments (S-ICDs) based on product type. In 2023, the T-ICDs segment held the dominant position in the market. This dominance is attributed to the valuable advantages offered by T-ICDs in managing life-threatening ventricular arrhythmias, as well as in reducing procedural complications and medical costs associated with invasive surgeries. T-ICDs cater to the needs of patients with ventricular fibrillation (VF) and ventricular tachycardia (VT) through features like permanent pacing, cardiac resynchronization therapy (CRT), and anti-tachycardia pacing.

The market is divided into three categories based on Device type: single-chamber ICDs, dual-chamber ICDs, and biventricular devices. In 2023, the biventricular devices segment emerged as the market leader. Factors such as the increasing prevalence of sudden cardiac deaths and its dual functionality as a pacemaker and a defibrillator are anticipated to drive the demand for CRT-D devices. The ability to promptly report adverse conditions, combined with enhanced pacing performance, contributes to reducing mortality rates. Moreover, major players are concentrating on enhancing these devices. For instance, in March 2019, BIOTRONIK introduced the smallest CRT-D and ICD devices globally in the European market, which were approved for 3 Tesla full-body MRI scans. Additionally, technological advancements in this segment, such as MRI compatibility, Bluetooth capability, and quadripolar leads, have the potential to enhance adoption rates. For example, in July 2020, Abbott announced FDA approval for its next-generation Bluetooth-enabled CRT-D and ICD devices.

Implantable cardioverter defibrillators Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Implantable cardioverter defibrillators Market- Competitive Landscape:

Companies operating in the implantable cardioverter defibrillators (ICD) market are employing various strategies to enhance their offerings. These strategies encompass technological advancements aimed at improving device efficacy and patient outcomes, such as miniaturization to enable less invasive procedures and prolonging battery life. Furthermore, companies are concentrating on the development of intelligent devices equipped with remote monitoring capabilities to facilitate proactive patient management and data-driven decision-making. Collaborations with healthcare providers and research institutions play a pivotal role in fostering continuous innovation and ensuring the integration of the latest medical advancements. Additionally, efforts directed towards regulatory compliance and adherence to stringent quality standards serve to reinforce consumer trust and enhance market penetration, thereby fostering sustained growth in the ICD market.

Recent Developments:

In June 2023, BIOTRONIK SE & Co. KG entered into a partnership with Royal Philips aimed at expanding the latter's admission to cardiovascular devices. Philips SymphonySuite, the primary entity solution available for cardiovascular care in Ambulatory Surgery Centers (ASCs) and office-based labs, stands as a testament to this collaborative effort.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott

Medtronic

BIOTRONIK SE & Co. KG

Boston Scientific Corporation

MicroPort Scientific Corporation.

LivaNova PLC.

Others

GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Transvenous Implantable Cardioverter-Defibrillators
Subcutaneous Implantable Cardioverter Defibrillators

GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY DEVICE TYPE- MARKET ANALYSIS, 2019 - 2032

Single Chamber ICDs
Dual Chamber ICDs
Biventricular Devices

GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY NYHA CLASS TYPE- MARKET ANALYSIS, 2019 - 2032

NYHA Class II
NYHA Class III

GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Ambulatory Surgical Centers
Others

GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Implantable cardioverter defibrillators Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Implantable cardioverter defibrillators Market Snippet by Product Type
- 2.1.2.Implantable cardioverter defibrillators Market Snippet by Device Type
- 2.1.3.Implantable cardioverter defibrillators Market Snippet by NYHA Class Type
- 2.1.4.Implantable cardioverter defibrillators Market Snippet by End Use
- 2.1.5.Implantable cardioverter defibrillators Market Snippet by Country
- 2.1.6.Implantable cardioverter defibrillators Market Snippet by Region
2.2.Competitive Insights

3.Implantable cardioverter defibrillators Key Market Trends

3.1.Implantable cardioverter defibrillators Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Implantable cardioverter defibrillators Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Implantable cardioverter defibrillators Market Opportunities
3.4.Implantable cardioverter defibrillators Market Future Trends

4.Implantable cardioverter defibrillators Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Implantable cardioverter defibrillators Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Implantable cardioverter defibrillators Market Landscape

6.1.Implantable cardioverter defibrillators Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Implantable cardioverter defibrillators Market - By Product Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2.Transvenous Implantable Cardioverter-Defibrillators
- 7.1.3.Subcutaneous Implantable Cardioverter Defibrillators

8.Implantable cardioverter defibrillators Market - By Device Type

8.1.Overview
- 8.1.1.Segment Share Analysis, By Device Type, 2023 & 2032 (%)
- 8.1.2.Single Chamber ICDs
- 8.1.3.Dual Chamber ICDs
- 8.1.4.Biventricular Devices

9.Implantable cardioverter defibrillators Market - By NYHA Class Type

9.1.Overview
- 9.1.1.Segment Share Analysis, By NYHA Class Type, 2023 & 2032 (%)
- 9.1.2.NYHA Class II
- 9.1.3.NYHA Class III

10.Implantable cardioverter defibrillators Market - By End Use

10.1.Overview
- 10.1.1.Segment Share Analysis, By End Use, 2023 & 2032 (%)
- 10.1.2.Hospitals
- 10.1.3.Ambulatory Surgical Centers
- 10.1.4.Others

11.Implantable cardioverter defibrillators Market- By Geography

11.1.Introduction
- 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2.North America
- 11.2.1.Overview
- 11.2.2.Implantable cardioverter defibrillators Key Manufacturers in North America
- 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.5.North America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
- 11.2.6.North America Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
- 11.2.7.North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.2.8.U.S.
  - 11.2.8.1.Overview
  - 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4.U.S. Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.2.8.5.U.S. Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.2.8.6.U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.2.9.Canada
  - 11.2.9.1.Overview
  - 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4.Canada Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.2.9.5.Canada Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.2.9.6.Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.3.Europe
- 11.3.1.Overview
- 11.3.2.Implantable cardioverter defibrillators Key Manufacturers in Europe
- 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.5.Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
- 11.3.6.Europe Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
- 11.3.7.Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.8.Germany
  - 11.3.8.1.Overview
  - 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4.Germany Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.3.8.5.Germany Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.3.8.6.Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.9.Italy
  - 11.3.9.1.Overview
  - 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4.Italy Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.3.9.5.Italy Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.3.9.6.Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.10.United Kingdom
  - 11.3.10.1.Overview
  - 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4.United Kingdom Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.3.10.5.United Kingdom Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.3.10.6.United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.11.France
  - 11.3.11.1.Overview
  - 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4.France Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.3.11.5.France Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.3.11.6.France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.12.Russia
  - 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3.Russia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4.Russia Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.3.12.5.Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.13.Netherlands
  - 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3.Netherlands Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4.Netherlands Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.3.13.5.Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.14.Sweden
  - 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3.Sweden Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4.Sweden Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.3.14.5.Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.15.Poland
  - 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3.Poland Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4.Poland Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.3.15.5.Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.3.16.Rest of Europe
  - 11.3.16.1.Overview
  - 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4.Rest of the Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.3.16.5.Rest of the Europe Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.3.16.6.Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.4.Asia Pacific (APAC)
- 11.4.1.Overview
- 11.4.2.Implantable cardioverter defibrillators Key Manufacturers in Asia Pacific
- 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.5.Asia Pacific Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
- 11.4.6.Asia Pacific Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
- 11.4.7.Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.8.India
  - 11.4.8.1.Overview
  - 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4.India Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.4.8.5.India Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.4.8.6.India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.9.China
  - 11.4.9.1.Overview
  - 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4.China Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.4.9.5.China Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.4.9.6.China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.10.Japan
  - 11.4.10.1.Overview
  - 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4.Japan Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.4.10.5.Japan Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.4.10.6.Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.11.South Korea
  - 11.4.11.1.Overview
  - 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4.South Korea Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.4.11.5.South Korea Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.4.11.6.South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.12.Australia
  - 11.4.12.1.Overview
  - 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4.Australia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.4.12.5.Australia Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.4.12.6.Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.13.Thailand
  - 11.4.13.1.Overview
  - 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4.Thailand Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.4.13.5.Thailand Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.4.13.6.Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.14.Indonesia
  - 11.4.14.1.Overview
  - 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4.Indonesia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.4.14.5.Indonesia Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.4.14.6.Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.15.Philippines
  - 11.4.15.1.Overview
  - 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4.Philippines Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.4.15.5.Philippines Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.4.15.6.Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.4.16.Rest of APAC
  - 11.4.16.1.Overview
  - 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4.Rest of APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.4.16.5.Rest of APAC Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.4.16.6.Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.5.Latin America
- 11.5.1.Overview
- 11.5.2.Implantable cardioverter defibrillators Key Manufacturers in Latin America
- 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.5.Latin America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
- 11.5.6.Latin America Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
- 11.5.7.Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.8.Brazil
  - 11.5.8.1.Overview
  - 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4.Brazil Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.5.8.5.Brazil Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.5.8.6.Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.9.Mexico
  - 11.5.9.1.Overview
  - 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4.Mexico Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.5.9.5.Mexico Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.5.9.6.Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.10.Argentina
  - 11.5.10.1.Overview
  - 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4.Argentina Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.5.10.5.Argentina Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.5.10.6.Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.11.Colombia
  - 11.5.11.1.Overview
  - 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4.Colombia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.5.11.5.Colombia Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.5.11.6.Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.5.12.Rest of LATAM
  - 11.5.12.1.Overview
  - 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4.Rest of LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.5.12.5.Rest of LATAM Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.5.12.6.Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11.6.Middle East and Africa
- 11.6.1.Overview
- 11.6.2.Implantable cardioverter defibrillators Key Manufacturers in Middle East and Africa
- 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.5.Middle East and Africa Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
- 11.6.6.Middle East and Africa Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
- 11.6.7.Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.8.Saudi Arabia
  - 11.6.8.1.Overview
  - 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4.Saudi Arabia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.6.8.5.Saudi Arabia Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.6.8.6.Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.9.United Arab Emirates
  - 11.6.9.1.Overview
  - 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4.United Arab Emirates Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.6.9.5.United Arab Emirates Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.6.9.6.United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.10.Israel
  - 11.6.10.1.Overview
  - 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4.Israel Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.6.10.5.Israel Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.6.10.6.Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.11.Turkey
  - 11.6.11.1.Overview
  - 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4.Turkey Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.6.11.5.Turkey Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.6.11.6.Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.12.Algeria
  - 11.6.12.1.Overview
  - 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4.Algeria Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.6.12.5.Algeria Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.6.12.6.Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.13.Egypt
  - 11.6.13.1.Overview
  - 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4.Egypt Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.6.13.5.Egypt Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.6.13.6.Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 11.6.14.Rest of MEA
  - 11.6.14.1.Overview
  - 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4.Rest of MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  - 11.6.14.5.Rest of MEA Market Size and Forecast, By NYHA Class Type, 2019 - 2032 (US$ Million)
  - 11.6.14.6.Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Implantable cardioverter defibrillators Industry

12.1.Competitive Dashboard
12.2.Company Profiles
- 12.2.1.Abbott
- 12.2.2.Medtronic
- 12.2.3.BIOTRONIK SE & Co. KG
- 12.2.4.Boston Scientific Corporation
- 12.2.5.MicroPort Scientific Corporation.
- 12.2.6.LivaNova PLC.
- 12.2.7.Others

13.360 Degree Analyst View

14.Appendix

14.1.Research Methodology
14.2.References
14.3.Abbreviations
14.4.Disclaimer
14.5.Contact Us